Nanion コーポレートブログ


27.07.2020 - European Innovation Radar identifies Nanion as a Key Innovator

Nanion successfully characterized ion channels in the red blood cell membrane by employing state-of-the-art Automated Patch Clamp technology.

The Innovation Radar platform builds on the information and data gathered by independent experts involved in reviewing ongoing research and innovation projects funded by the European Commission. These experts also provided an independent view regarding the innovations in the projects and their market potential (more information about the Innovation Radar methodology is available here).

The aim is to make information about EU-funded innovations from high-quality projects visible and accessible to the public via the EU's Innovation Radar platform. This will show citizens the many excellent technological and scientific advances being delivered by researchers and innovators around Europe, funded on their behalf by the European Commission. This initiative has the support of EU Members States and, to date, Ministers from 23 countries have signed the Innovation Radar declaration confirming their support for this initiative.

Project Title: Regulation of red cell life-span, erythropoiesis, survival, senescence and clearance
Innovation: Patch clamp method to evaluate the electrophysiology properties of red blood cells 

RELEVANCE is an international consortium of thirteen partners representing academic research centres, diagnostic labs, blood supply centres, and small industries that combines basic and translational research to improve prognostic, diagnostic and therapeutic approaches on red blood cells production, function, and clearance in healthy humans and patients.

Read more about the project here



We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.